Tiziana Life Sciences Ltd

TLSANASDAQHealthcare● Active

$1.22

$-0.00(-0.41%)

Market Cap$72202592

P/E Ratio—

52W High$2.6

52W Low$1.08

Avg Volume196K

Open$1.21

Beta0.42

Overview

Tiziana Life Sciences Ltd (TLSA) Revenue

Annual & quarterly revenue history · segment & region breakdown

TLSA · revenue · updated Jun 9, 2026

Core revenue metrics

Trailing 12 months

Tiziana Life Sciences Ltd trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.

TTM revenue

$0.00B

4-quarter sum · USD

YoY growth

+0.00%

vs FY —

Price / sales

—

mktCap ÷ TTM rev

Revenue per day

—

Est. TTM ÷ 365

Revenue / employee

$0K

9 employees

—

5Y CAGR

—

Fiscal year end

Dec 31

Currency

USD · GAAP

Filing

10-K / 10-Q

Source: FMP · Tiziana Life Sciences Ltd SEC filings · GAAPUpdated: 2026-06-09

Revenue trend

– · Annual

YoY revenue growth %

revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year end	Revenue	Change	Growth

TLSA revenue by year · TLSA revenue history · TLSA annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income Tiziana Life Sciences Ltd receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

Tiziana Life Sciences Ltd reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from Tiziana Life Sciences Ltd's 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Price history Financial statements Forecast

Frequently asked questions

TLSA revenue · 4 questions

TLSA's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.

TLSA revenueTLSA annual revenuewhat is TLSA revenueTLSA TTM revenue

▸ Source: FMP · Tiziana Life Sciences Ltd SEC filings · GAAP · Tiziana Life Sciences Ltd SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026